It is clear that 4-1BB expression is often confined to a small subset of tumor-resident T cells (most often less than 20%), and many of these can be Treg, or it is only seen in certain tumor types and not others, while most conventional CD8 and CD4 T cells within tumors may lack 4-1BB (90–94). This evidence concerns the gene CD4 and neoplasm.